Similar articles

• [Presymptomatic DNA diagnosis in Huntington chorea with linked DNA markers].

  Thies U, Schröder K, Bockel B, Zoll B, Lange H. Thies U, et al. Nervenarzt. 1991 Oct;62(10):615-20. Nervenarzt. 1991. PMID: 1684226 German. No abstract available.
• Ethical issues in the care of patients with amyotrophic lateral sclerosis. Società Italiana di Neurologia (SIN) Working Group "Bioethics and Neurology".

  [No authors listed] [No authors listed] Ital J Neurol Sci. 1995 Jun;16(5):329-32. Ital J Neurol Sci. 1995. PMID: 8537222 No abstract available.
• Ethical issues in preclinical testing in Huntington disease: response to Margery Shaw's invited editorial comment.

  Hayden MR, Bloch M, Fox S, Crauford D. Hayden MR, et al. Am J Med Genet. 1987 Nov;28(3):761-3. doi: 10.1002/ajmg.1320280329. Am J Med Genet. 1987. PMID: 2962495 No abstract available.
• [Huntington chorea: perspective changes in presymptomatic diagnosis (updating synthetic review)].

  Borri G. Borri G. Riv Neurol. 1989 Nov-Dec;59(6):223-8. Riv Neurol. 1989. PMID: 2534779 Review. Italian.
• Informed consent and Huntington disease: a model for communication.

  Sharpe NF. Sharpe NF. Am J Med Genet. 1994 Apr 15;50(3):239-46. doi: 10.1002/ajmg.1320500306. Am J Med Genet. 1994. PMID: 8042667 Review.